PCA
Personal Capital Advisors’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $573K | Buy |
12,376
+2,151
| +21% | +$99.5K | ﹤0.01% | 283 |
|
|
2022
Q3 | $396K | Buy |
10,225
+2,265
| +28% | +$87.7K | ﹤0.01% | 317 |
|
|
2022
Q2 | $297K | Buy |
7,960
+53
| +0.7% | +$1.98K | ﹤0.01% | 354 |
|
|
2022
Q1 | $350K | Sell |
7,907
-1,634
| -17% | -$72.3K | ﹤0.01% | 356 |
|
|
2021
Q4 | $402K | Buy |
9,541
+1,245
| +15% | +$52.5K | ﹤0.01% | 373 |
|
|
2021
Q3 | $360K | Buy |
8,296
+2,315
| +39% | +$100K | ﹤0.01% | 362 |
|
|
2021
Q2 | $256K | Buy |
5,981
+17
| +0.3% | +$728 | ﹤0.01% | 424 |
|
|
2021
Q1 | $231K | Sell |
5,964
-799
| -12% | -$30.9K | ﹤0.01% | 439 |
|
|
2020
Q4 | $243K | Sell |
6,763
-254
| -4% | -$9.13K | ﹤0.01% | 418 |
|
|
2020
Q3 | $268K | Sell |
7,017
-232
| -3% | -$8.86K | ﹤0.01% | 352 |
|
|
2020
Q2 | $255K | Buy |
7,249
+99
| +1% | +$3.48K | ﹤0.01% | 314 |
|
|
2020
Q1 | $233K | Sell |
7,150
-1,869
| -21% | -$60.9K | ﹤0.01% | 315 |
|
|
2019
Q4 | $408K | Buy |
9,019
+1,790
| +25% | +$81K | ﹤0.01% | 288 |
|
|
2019
Q3 | $294K | Buy |
7,229
+119
| +2% | +$4.84K | ﹤0.01% | 297 |
|
|
2019
Q2 | $306K | Buy |
7,110
+327
| +5% | +$14.1K | ﹤0.01% | 272 |
|
|
2019
Q1 | $260K | Buy |
6,783
+9
| +0.1% | +$345 | ﹤0.01% | 286 |
|
|
2018
Q4 | $239K | Sell |
6,774
-106
| -2% | -$3.74K | ﹤0.01% | 278 |
|
|
2018
Q3 | $265K | Sell |
6,880
-60
| -0.9% | -$2.31K | ﹤0.01% | 258 |
|
|
2018
Q2 | $227K | Sell |
6,940
-2,424
| -26% | -$79.3K | ﹤0.01% | 263 |
|
|
2018
Q1 | $256K | Buy |
+9,364
| New | +$256K | ﹤0.01% | 237 |
|
|
2014
Q2 | – | Sell |
-10,000
| Closed | -$135K | – | 88 |
|
|
2014
Q1 | $135K | Buy |
+10,000
| New | +$135K | 0.03% | 87 |
|